Lexicon s 2000 Revenues Triple While Losses Widen Sharply | GenomeWeb

NEW YORK, March 7 - Lexicon Genetics' year-end revenues increased 205 percent to $14.5 million from over $4.7 million in 1999, while increased expenses and stock compensation drove its losses up substantially for 2000, the company reported Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.